1. Home
  2. ECO vs URGN Comparison

ECO vs URGN Comparison

Compare ECO & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okeanis Eco Tankers Corp.

ECO

Okeanis Eco Tankers Corp.

HOLD

Current Price

$90.09

Market Cap

2.1B

Sector

N/A

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$35.12

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECO
URGN
Founded
2018
2004
Country
Greece
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
ECO
URGN
Price
$90.09
$35.12
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
★ $69.67
$60.00
AVG Volume (30 Days)
734.1K
★ 824.4K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
★ 10.47%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,128,000.00
Revenue This Year
$116.49
$193.48
Revenue Next Year
N/A
$64.99
P/E Ratio
$18.60
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$31.75
$16.50
52 Week High
$100.68
$50.81

Technical Indicators

Market Signals
Indicator
ECO
URGN
Relative Strength Index (RSI) 57.10 33.73
Support Level $47.47 $34.18
Resistance Level $100.68 $44.27
Average True Range (ATR) 4.32 2.25
MACD -0.93 -0.27
Stochastic Oscillator 29.31 18.93

Price Performance

Historical Comparison
ECO
URGN

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: